Bulut, I., Lee, A., Cevatemre, B., Ruzic, D., Belle, R., Kawamura, A., . . . Acilan, C. (2022). Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers, 14(23), 6014. https://doi.org/10.3390/cancers14236014
Chicago Style (17th ed.) CitationBulut, Ipek, et al. "Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells." Cancers 14, no. 23 (2022): 6014. https://doi.org/10.3390/cancers14236014.
MLA (9th ed.) CitationBulut, Ipek, et al. "Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells." Cancers, vol. 14, no. 23, 2022, p. 6014, https://doi.org/10.3390/cancers14236014.
Warning: These citations may not always be 100% accurate.